Developing hyperbolic dose reduction frameworks for typical and atypical antipsychotics, specifically engineered to mitigate neuro-receptor shock and physiological withdrawal syndromes.
Auditing multi-drug regimens where drug-induced adverse reactions are misidentified as novel psychiatric conditions, resulting in unmonitored compounding prescriptions.
Building a forensic public record of systemic care failures, uncoordinated multi-provider drug casualties, and empirical long-term patient recovery timelines.
Our complete directory of clinical protocols and case archives is undergoing data verification prior to public release. We welcome preliminary data, clinical observations, and correspondence.